RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding RAPT Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 85 | 98 | +13 |
| Shares | 29.7M | 30.0M | +249.4K (+0.8%) |
| Value | $542.7M | $721.0M | +$178.3M (+32.9%) |
New holders (22)
Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (9)
Institutions that held RAPT Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HealthCor Management, L.P. | 217,165 | $3.96M |
| Walleye Capital LLC | 38,320 | $699.0K |
| Man Group plc | – | $374.0K |
| Ergoteles LLC | 12,600 | $230.0K |
| Two Sigma Investments, LP | 11,800 | $215.0K |
| Trustees of the University of Pennsylvania | 10,031 | $183.0K |
| Quantbot Technologies LP | 5,870 | $107.0K |
| Group One Trading, L.P. | 232 | $4.00K |
| Northwestern Mutual Wealth Management Co | 12 | $0 |